https://sudonull.com/oncolytics-biotech-immunotherapy-for-pancreatic-cancer-asco-2026
Oncolytics Biotech data at ASCO 2026: pelareorep virus activates T cells against mutant KRAS in pancreatic cancer. Learn about the breakthrough in treating 'cold' tumors.
https://sudonull.com/mrna-vaccines-became-3-times-more-effective-breakthrough-by-mt-sinai
Mount Sinai scientists refuted the dogma of mRNA vaccine function. Suppressing expression in the liver triples the immune response. Learn about the revolution in cancer therapy and toxicity reduction.
https://sudonull.com/replacement-of-gold-nanoparticles-for-laser-cancer-treatment-in-russia
Russian scientists replaced expensive gold with tungsten and palladium diselenides for photothermal cancer therapy. Learn about a cheap and safe method for destroying inoperable tumors.
https://sudonull.com/daraxonacib-for-pancreatic-cancer-risks-and-survival
The drug daraxonacib doubled survival in pancreatic cancer but does not cure. Learn about mechanisms, side effects, and real limits of the breakthrough. Read the analysis.
https://sudonull.com/ai-gps-predicts-drugs-for-liver-cancer
GPS Platform Analyzes Molecules to Find Treatments for HCC and IPF. Tests on Mice and Tissues Confirmed Efficacy. Open the Code and Apply to Your Tasks in drug discovery.
https://ymaho.com/mit-nanoparticles-for-immunotherapy-of-pancreatic-cancer-metastases
MIT scientists have created nanoparticles with AND logic for targeted activation of the STING pathway in metastases. Preclinical data: 70% reduction in metastases. Learn about the breakthrough in nanomedicine.
https://ymaho.com/cd4-t-cells-kill-cancer-through-ferroptosis-a-breakthrough-in-immunology
Scientists have proven: CD4+ T lymphocytes destroy MHC I-negative tumors through ferroptosis. The discovery changes the approach to cancer immunotherapy and treatment of GVHD. Read the details.
https://ymaho.com/new-microproteins-in-junk-dna-1700-peptideins-reveal-targets-for-immunotherapy
TransCODE scientists discovered over 1700 microproteins in non-coding DNA. Silencing the OLMALINC gene reduces cancer cell survival by 85%. Learn how peptideins are changing oncology and immunotherapy.
https://ymaho.com/peptideins-from-junk-dna-1700-new-microproteins-kill-cancer
Scientists have discovered over 1700 microproteins in non-coding DNA, becoming new targets for cancer. Learn how peptideins change immunotherapy and oncovaccines. Read breakthrough details!
https://ymaho.com/new-type-of-cellular-immune-bomb-ruptosis-against-cancer
Mechanism of ruptosis discovered: kamikaze cells explode, destroying tumors locally. Learn how this will change cancer immunotherapy and infection control.
https://ymaho.com/moderna-vaccine-shrank-tumors-in-83-of-melanoma-patients
mRNA drug mRNA-4359 with Keytruda showed 83% response and 17% complete remissions. Even PD-L1-negative tumors shrank. Learn how a ready-made vaccine teaches the immune system to attack cancer without personalization.
https://ymaho.com/fda-approval-of-combination-immunotherapy-for-bladder-cancer-durvalumab-bcg
FDA approved durvalumab with BCG for high-risk NMIBC. POTOMAC data: 32% risk reduction. Analysis of efficacy, toxicity, and consequences of BCG shortage. Learn more.
https://ymaho.com/immunotherapy-for-braf-colorectal-cancer-new-data-from-nature-medicine
Analysis of the efficacy of encorafenib and binimetinib combination in BRAF-mutant colorectal cancer. Results, limitations, prognosis, and side effects. Read more.
https://ymaho.com/immunotherapy-for-endometrial-cancer-asco-2026-data
Analysis of the NRG-GY018 study: pembrolizumab + chemotherapy improved survival in endometrial cancer. Risk of death reduced by 44% in dMMR. Details at ASCO 2026.
https://ymaho.com/lung-cancer-drug-lurbinectedin-approved-in-europe
Europe approved the world's first Lurbinectedin drug with immunotherapy for aggressive lung cancer. 46% reduction in risk of death. Learn about the breakthrough and forecasts.
Learn how to use Terraform with AWS step by step. Master provider setup, state management, security, and production-grade deployments. Start building today.
Learn what is Kubernetes and how it works. Understand its architecture, self-healing, scaling benefits, and real-world impact. Start mastering container orchestration today.
Google and Quantinuum have reached the threshold of scalable quantum error correction. Learn how this changes the future of quantum computing and who benefits from the breakthrough.
Docker container networking explained in depth: learn bridge vs host networks, DNS, port publishing, and how to build secure, scalable multi-container apps.
Learn what is object oriented programming, its four pillars, real-world examples, and why it matters for building scalable, maintainable software. Start mastering OOP today.
Figure AI introduced the humanoid robot Figure 02 with physical AI and OpenAI language model. The robot passed tests at BMW factories. Learn how humanoid robots are changing manufacturing.
Learn what is the difference between vpn and proxy, from encryption to scope. Discover which tool fits your privacy needs with our expert comparison.
PostgreSQL vs MySQL which one to choose? Compare features, performance, scalability, and use cases. Make an informed decision for your project with this data-driven guide.
Learn how to deploy LLM in production with this step-by-step guide. Covers model selection, Kubernetes deployment, vLLM, testing, and monitoring for reliable AI systems.
React vs Vue which framework to choose in 2025? Compare performance, learning curves, job markets, and costs. Make a data-driven decision for your next project.